Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: August 17, 2022

Drugs in MeSH Category Antipruritics

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan	LORATADINE	loratadine	TABLET;ORAL	075790-001	Nov 7, 2008		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Akorn	KETOTIFEN FUMARATE	ketotifen fumarate	SOLUTION/DROPS;OPHTHALMIC	077958-001	Jul 26, 2007		OTC	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Mylan	PROMETHAZINE HYDROCHLORIDE	promethazine hydrochloride	TABLET;ORAL	091054-001	Aug 30, 2011		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Watson Labs	PROMETHAZINE HYDROCHLORIDE	promethazine hydrochloride	TABLET;ORAL	083204-001	Approved Prior to Jan 1, 1982		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Nesher Pharms	ONDANSETRON	ondansetron	TABLET, ORALLY DISINTEGRATING;ORAL	077717-001	Jun 25, 2007		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Sun Pharm Inds Inc	PROMETHAZINE HYDROCHLORIDE	promethazine hydrochloride	TABLET;ORAL	040863-002	Dec 30, 2008	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Prinston Inc	PROMETHAZINE HYDROCHLORIDE	promethazine hydrochloride	TABLET;ORAL	040622-002	Jul 18, 2006	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey

AstraZeneca

Dow

Medtronic

Boehringer Ingelheim

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.